Skip to content
August 17, 2026
  • Pre-Surgical Complications (Part 6) — The Decision
  • The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute
  • Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs
  • Better Models Won’t Fix Pharma’s AI Problem — Better Terminology Will

Medical Article

Newsletter
Random News
Headlines
  • Pre-Surgical Complications (Part 6) — The Decision

    1 hour ago
  • The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute

    10 hours ago
  • Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs

    10 hours ago
  • Better Models Won’t Fix Pharma’s AI Problem — Better Terminology Will

    19 hours ago
  • The True Cost of Focusing on Cost Instead of Cost-Effectiveness

    19 hours ago
  • Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order

    2 days ago
  • Home
  • Friday Links
  • Articles

Friday Links

6 months ago01 mins

Expert opinions: Will MFN reduce US drug prices?Robots in maternity care.What drives company decisions on new medicine launches and UK investment?Incorporating dynamic pricing into HEOR models (dynamicpv)Tale of 2 value sets.How to handle the lows? Honesty.Integrity in journalism: Giannis edition.

Post navigation

Previous: AI Can’t Improve Healthcare if Clinicians and Staff Aren’t Trained to Use, Orchestrate It
Next: Closing the CKD Care Gap with Value-Based Care Models

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Pre-Surgical Complications (Part 6) — The Decision

1 hour ago 0

Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order

2 days ago 0

Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage

3 days ago 0

My Husband Was Kicked Out of Hospice for Dying Too Slowly

3 days ago 0

Recent Posts

  • Pre-Surgical Complications (Part 6) — The Decision
  • The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute
  • Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs
  • Better Models Won’t Fix Pharma’s AI Problem — Better Terminology Will
  • The True Cost of Focusing on Cost Instead of Cost-Effectiveness

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.